Home > National Drug Code (NDC) > DR. RECKEWEG R13 Prohaemorrhin

DR. RECKEWEG R13 Prohaemorrhin - 53346-1313-5 - (Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X)

Alphabetical Index


Drug Information of DR. RECKEWEG R13 Prohaemorrhin

Product NDC: 53346-1313
Proprietary Name: DR. RECKEWEG R13 Prohaemorrhin
Non Proprietary Name: Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X
Active Ingredient(s): 4; 8; 3; 2; 5; 6; 3; 6; 4; 5    [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL & nbsp;   Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of DR. RECKEWEG R13 Prohaemorrhin

Product NDC: 53346-1313
Labeler Name: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 19860601

Package Information of DR. RECKEWEG R13 Prohaemorrhin

Package NDC: 53346-1313-5
Package Description: 50 mL in 1 BOTTLE (53346-1313-5)

NDC Information of DR. RECKEWEG R13 Prohaemorrhin

NDC Code 53346-1313-5
Proprietary Name DR. RECKEWEG R13 Prohaemorrhin
Package Description 50 mL in 1 BOTTLE (53346-1313-5)
Product NDC 53346-1313
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 19860601
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Substance Name COLLINSONIA CANADENSIS ROOT; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PAEONIA OFFICINALIS ROOT; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR
Strength Number 4; 8; 3; 2; 5; 6; 3; 6; 4; 5
Strength Unit [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
Pharmaceutical Classes

Complete Information of DR. RECKEWEG R13 Prohaemorrhin


General Information